企業プロフィール
Henry Schein 株価・ニュース・カタリスト
- ティッカー:
- HSIC
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
89.52 USD (-0.28%)
終値
最終更新: 2026年8月17日
8.66B USD
時価総額
株価変動の要因
As of Aug 17, 2026, HSIC closed down 0.28% at $89.52. No new same-company headline was identified in the current news window.
企業概要
事業概要
Henry Schein is a global distributor of healthcare and dental products, with businesses spanning clinical supplies, equipment, and software. Its role is centered on healthcare distribution and practice support rather than biotech or medtech innovation.
所在地とセクター分類
Headquartered in the United States and listed on NASDAQ, Henry Schein has a global distribution footprint. It sits in healthcare distribution and dental supply rather than biotechnology.
ビジネスモデルの特徴
The company generates revenue from product distribution, equipment sales, and software services for providers. Investors watch end-market demand, margin stability, and the health of dental and medical office spending.
バイオ業界での位置付け
Henry Schein is outside biotech, but it is part of the healthcare infrastructure that keeps clinical and dental practices operating. It moves on distribution volumes and practice demand, not drug catalysts.
今後のカタリスト
- Henry Schein’s catalysts are dental-market recovery, software adoption, and inventory / margin discipline. The key question is whether the update shows enough repeatable demand to look like a durable revenue driver rather than a one-quarter bump. If adoption broadens, sentiment can improve faster than the reported numbers alone would suggest.
最近のニュース
- 01
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。